Line probe assay for monitoring drug resistance in hepatitis B virus-infected patients during antiviral therapy

被引:165
作者
Stuyver, L
Van Geyt, C
De Gendt, S
Van Reybroeck, G
Zoulim, F
Leroux-Roels, G
Rossau, R
机构
[1] Innogenet NV, B-9052 Ghent, Belgium
[2] Ghent Univ Hosp, Dept Clin Chem, B-9000 Ghent, Belgium
[3] INSERM, U271, F-69008 Lyon, France
关键词
D O I
10.1128/JCM.38.2.702-707.2000
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Since the introduction of antiviral compounds such as lamivudine and famciclovir in the treatment schedules of patients with chronic hepatitis B virus (HBV) infection, the accumulation of a variety of mutations in the HBV polymerase gene has been observed. The selection of these mutations is generally considered the cause of viral nonresponsiveness and treatment failure, Therefore, the detection of these mutations is of clinical importance. Previously genotyped HBV strains isolated from treated and untreated patients were amplified with primers specific for the I-IBV polymerase region from amino acids 465 to 562, Amplified products were cloned into plasmid vectors, The clones were used as reference strains. A set of 38 highly specific oligonucleotide probes covering three different codon positions, L528M, M552V/I, and V/L/M555I, were selected, These probes were applied as 19 different lines on a membrane strip. The strips were then hybridized with PCR fragments from the reference panel, revealing the amino acids at the three codon positions simultaneously for each clone. PCR products generated from two patients infected with HBV genotypes A and C, respectively, and treated with nucleoside analogs were analyzed on these strips, A gradual increase in genetic HEY polymerase complexity was observed in follow-up samples compared to that in pretreatment samples, Additional analysis of HBV polymerase DNA fragments in recombinant plasmid clones demonstrated the existence of ii) clones dth double mutations, iii) clones with single mutations at either codon 528, 552, or 555, and (iii) the simultaneous occurrence of two or more,viral populations within one sample, This line probe assay detected the complex quasispecies nature of HBV and provided some insight into the dynamics of resistance mutations.
引用
收藏
页码:702 / 707
页数:6
相关论文
共 28 条
  • [1] Identification and characterization of mutations in hepatitis B virus resistant to lamivudine
    Allen, MI
    Deslauriers, M
    Andrews, CW
    Tipples, GA
    Walters, KA
    Tyrrell, DLJ
    Brown, N
    Condreay, LD
    [J]. HEPATOLOGY, 1998, 27 (06) : 1670 - 1677
  • [2] Bartholomeusz A., 1998, VIRAL HEPATITIS REV, V4, P167
  • [3] Transient emergence of hepatitis B variants in a patient with chronic hepatitis B resistant to lamivudine
    Buti, M
    Jardi, R
    Cotrina, M
    Rodriguez-Frias, F
    Esteban, R
    Guardia, J
    [J]. JOURNAL OF HEPATOLOGY, 1998, 28 (03) : 510 - 513
  • [4] Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy
    Chayama, K
    Suzuki, Y
    Kobayashi, M
    Kobayashi, M
    Tsubota, A
    Hashimoto, M
    Miyano, Y
    Koike, H
    Kobayashi, M
    Koida, I
    Arase, Y
    Saitoh, S
    Murashima, N
    Ikeda, K
    Kumada, H
    [J]. HEPATOLOGY, 1998, 27 (06) : 1711 - 1716
  • [5] Absence of mutations in the YMDD motif/B region of the hepatitis B virus polymerase in famciclovir therapy failure
    Günther, S
    von Breunig, F
    Santantonio, T
    Jung, MC
    Gaeta, GB
    Fischer, L
    Sterneck, M
    Will, H
    [J]. JOURNAL OF HEPATOLOGY, 1999, 30 (05) : 749 - 754
  • [6] Naturally occurring hepatitis B virus genomes bearing the hallmarks of retroviral G->A hypermutation
    Gunther, S
    Sommer, G
    Plikat, U
    Iwanska, A
    WainHobson, S
    Will, H
    Meyerhans, A
    [J]. VIROLOGY, 1997, 235 (01) : 104 - 108
  • [7] Heijtink RA, 1997, J MED VIROL, V53, P282, DOI 10.1002/(SICI)1096-9071(199711)53:3<282::AID-JMV18>3.3.CO
  • [8] 2-S
  • [9] Lamivudine resistance in immunocompetent chronic hepatitis B - Incidence and patterns
    Honkoop, P
    Niesters, HGM
    deMan, RAM
    Osterhaus, ADME
    Schalm, SW
    [J]. JOURNAL OF HEPATOLOGY, 1997, 26 (06) : 1393 - 1395
  • [10] The M539V polymerase variant of human hepatitis B virus demonstrates resistance to 2′-deoxy-3′-thiacytidine and a reduced ability to synthesize viral DNA
    Ladner, SK
    Miller, TJ
    King, RW
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (08) : 2128 - 2131